Clinical decisions in Hepatology: The pirfenidone case analysis

Saved in:
Bibliographic Details
Published in:Annals of hepatology 2014-03, Vol.13 (2), p.163-165
Main Authors: Chavez-Tapia, Norberte C., M.D, Méndez-Sánchez, Nahum
Format: Article
Language:English
Subjects:
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Drug Approval
Gastroenterology and Hepatology
Humans
Liver Cirrhosis - drug therapy
Mexico
Pyridones - therapeutic use
Translational Medical Research
United States
United States Food and Drug Administration
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c477t-ba0c61779818003af9c660ddf4487b61a35e76e06f7585fcf16b0828259fddb73
cites cdi_FETCH-LOGICAL-c477t-ba0c61779818003af9c660ddf4487b61a35e76e06f7585fcf16b0828259fddb73
container_end_page 165
container_issue 2
container_start_page 163
container_title Annals of hepatology
container_volume 13
creator Chavez-Tapia, Norberte C., M.D
Méndez-Sánchez, Nahum
description
doi_str_mv 10.1016/S1665-2681(19)30878-6
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ef8ec2d0881a44719308a257e0356ee7</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1665268119308786</els_id><doaj_id>oai_doaj_org_article_ef8ec2d0881a44719308a257e0356ee7</doaj_id><sourcerecordid>1501375328</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-ba0c61779818003af9c660ddf4487b61a35e76e06f7585fcf16b0828259fddb73</originalsourceid><addsrcrecordid>eNo9kU9PGzEQxX1oBZTyEVrtkR629djrP8uBCkUUkJA4AGfLa4-pw2Yd7AQp355NNuQ00ujNezO_IeQH0N9AQf55BClFzaSGc2h_caqVruUXcnJoH5NvpcwpbbgAdkSOWSME00KdkL-zPg7R2b7y6GKJaShVHKpbXNpV6tPL5qJ6-o_VMuaAQ_RpwMrZgpUdbL8psXwnX4PtC57t6yl5_nf9NLut7x9u7mZX97VrlFrVnaVOglKtBk0pt6F1UlLvQ9No1UmwXKCSSGVQQovgAsiOaqaZaIP3neKn5G7y9cnOzTLHhc0bk2w0u0bKL8bmVXQ9GgwaHfNUa7BNo6AdgVgmFFIuJOLW63zyWub0tsayMotYHPa9HTCtiwFBgSvBmR6lYpK6nErJGA7RQM2WvdmxN1vIBlqzY2_kOPdzH7HuFugPU5_gR8HlJMAR2nvEbNz-Ea-4wTJP6zwSHncxhRk6pWxDdtcoLfkH_cOUgg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1501375328</pqid></control><display><type>article</type><title>Clinical decisions in Hepatology: The pirfenidone case analysis</title><source>ScienceDirect - Connect here FIRST to enable access</source><creator>Chavez-Tapia, Norberte C., M.D ; Méndez-Sánchez, Nahum</creator><creatorcontrib>Chavez-Tapia, Norberte C., M.D ; Méndez-Sánchez, Nahum</creatorcontrib><identifier>ISSN: 1665-2681</identifier><identifier>DOI: 10.1016/S1665-2681(19)30878-6</identifier><identifier>PMID: 24552857</identifier><language>eng</language><publisher>Mexico: Elsevier</publisher><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Drug Approval ; Gastroenterology and Hepatology ; Humans ; Liver Cirrhosis - drug therapy ; Mexico ; Pyridones - therapeutic use ; Translational Medical Research ; United States ; United States Food and Drug Administration</subject><ispartof>Annals of hepatology, 2014-03, Vol.13 (2), p.163-165</ispartof><rights>Fundación Clínica Médica Sur, A.C.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-ba0c61779818003af9c660ddf4487b61a35e76e06f7585fcf16b0828259fddb73</citedby><cites>FETCH-LOGICAL-c477t-ba0c61779818003af9c660ddf4487b61a35e76e06f7585fcf16b0828259fddb73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24552857$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chavez-Tapia, Norberte C., M.D</creatorcontrib><creatorcontrib>Méndez-Sánchez, Nahum</creatorcontrib><title>Clinical decisions in Hepatology: The pirfenidone case analysis</title><title>Annals of hepatology</title><addtitle>Ann Hepatol</addtitle><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Drug Approval</subject><subject>Gastroenterology and Hepatology</subject><subject>Humans</subject><subject>Liver Cirrhosis - drug therapy</subject><subject>Mexico</subject><subject>Pyridones - therapeutic use</subject><subject>Translational Medical Research</subject><subject>United States</subject><subject>United States Food and Drug Administration</subject><issn>1665-2681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNo9kU9PGzEQxX1oBZTyEVrtkR629djrP8uBCkUUkJA4AGfLa4-pw2Yd7AQp355NNuQ00ujNezO_IeQH0N9AQf55BClFzaSGc2h_caqVruUXcnJoH5NvpcwpbbgAdkSOWSME00KdkL-zPg7R2b7y6GKJaShVHKpbXNpV6tPL5qJ6-o_VMuaAQ_RpwMrZgpUdbL8psXwnX4PtC57t6yl5_nf9NLut7x9u7mZX97VrlFrVnaVOglKtBk0pt6F1UlLvQ9No1UmwXKCSSGVQQovgAsiOaqaZaIP3neKn5G7y9cnOzTLHhc0bk2w0u0bKL8bmVXQ9GgwaHfNUa7BNo6AdgVgmFFIuJOLW63zyWub0tsayMotYHPa9HTCtiwFBgSvBmR6lYpK6nErJGA7RQM2WvdmxN1vIBlqzY2_kOPdzH7HuFugPU5_gR8HlJMAR2nvEbNz-Ea-4wTJP6zwSHncxhRk6pWxDdtcoLfkH_cOUgg</recordid><startdate>20140301</startdate><enddate>20140301</enddate><creator>Chavez-Tapia, Norberte C., M.D</creator><creator>Méndez-Sánchez, Nahum</creator><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>20140301</creationdate><title>Clinical decisions in Hepatology: The pirfenidone case analysis</title><author>Chavez-Tapia, Norberte C., M.D ; Méndez-Sánchez, Nahum</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-ba0c61779818003af9c660ddf4487b61a35e76e06f7585fcf16b0828259fddb73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Drug Approval</topic><topic>Gastroenterology and Hepatology</topic><topic>Humans</topic><topic>Liver Cirrhosis - drug therapy</topic><topic>Mexico</topic><topic>Pyridones - therapeutic use</topic><topic>Translational Medical Research</topic><topic>United States</topic><topic>United States Food and Drug Administration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chavez-Tapia, Norberte C., M.D</creatorcontrib><creatorcontrib>Méndez-Sánchez, Nahum</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Annals of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chavez-Tapia, Norberte C., M.D</au><au>Méndez-Sánchez, Nahum</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical decisions in Hepatology: The pirfenidone case analysis</atitle><jtitle>Annals of hepatology</jtitle><addtitle>Ann Hepatol</addtitle><date>2014-03-01</date><risdate>2014</risdate><volume>13</volume><issue>2</issue><spage>163</spage><epage>165</epage><pages>163-165</pages><issn>1665-2681</issn><cop>Mexico</cop><pub>Elsevier</pub><pmid>24552857</pmid><doi>10.1016/S1665-2681(19)30878-6</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1665-2681
ispartof Annals of hepatology, 2014-03, Vol.13 (2), p.163-165
issn 1665-2681
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_ef8ec2d0881a44719308a257e0356ee7
source ScienceDirect - Connect here FIRST to enable access
subjects Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Drug Approval
Gastroenterology and Hepatology
Humans
Liver Cirrhosis - drug therapy
Mexico
Pyridones - therapeutic use
Translational Medical Research
United States
United States Food and Drug Administration
title Clinical decisions in Hepatology: The pirfenidone case analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T01%3A42%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20decisions%20in%20Hepatology:%20The%20pirfenidone%20case%20analysis&rft.jtitle=Annals%20of%20hepatology&rft.au=Chavez-Tapia,%20Norberte%20C.,%20M.D&rft.date=2014-03-01&rft.volume=13&rft.issue=2&rft.spage=163&rft.epage=165&rft.pages=163-165&rft.issn=1665-2681&rft_id=info:doi/10.1016/S1665-2681(19)30878-6&rft_dat=%3Cproquest_doaj_%3E1501375328%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c477t-ba0c61779818003af9c660ddf4487b61a35e76e06f7585fcf16b0828259fddb73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1501375328&rft_id=info:pmid/24552857&rfr_iscdi=true